Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| 1 |
Advanced Micro Devices
AMD
|
$855M |
| 2 |
Samsara
IOT
|
$371M |
| 3 |
SolarEdge
SEDG
|
$272M |
| 4 |
Moderna
MRNA
|
$258M |
| 5 |
Floor & Decor
FND
|
$251M |
Top Sells
| 1 |
Salesforce
CRM
|
$439M |
| 2 |
Illumina
ILMN
|
$388M |
| 3 |
NVIDIA
NVDA
|
$379M |
| 4 |
FRC
First Republic Bank
FRC
|
$333M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$326M |
Sector Composition
| 1 | Consumer Discretionary | 27.8% |
| 2 | Healthcare | 22.38% |
| 3 | Technology | 21.76% |
| 4 | Communication Services | 11.88% |
| 5 | Financials | 5.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
226
New York Times
NYT
$9.74B
| $8.52M | 0.01% |
+219,149
| New | +$8.52M |
|
|
DCBO
227
Docebo
DCBO
$896M
| $8.27M | 0.01% |
203,361
-5,413
| -3% | -$220K |
|
228
Veeva Systems
VEEV
$44B
| $7.94M | 0.01% |
43,222
+324
| +0.8% | +$59.5K |
|
|
AKLI
229
DELISTED
Akili, Inc. Common Stock
AKLI
| $7.47M | 0.01% |
4,665,795
| – | – |
|
230
American Superconductor
AMSC
$2.25B
| $7.32M | 0.01% |
1,491,370
| – | – |
|
231
Oscar Health
OSCR
$4.31B
| $7.23M | 0.01% |
1,105,297
+5,218
| +0.5% | +$34.1K |
|
232
Quanterix
QTRX
$211M
| $7.12M | 0.01% |
631,897
-298
| -0% | -$3.36K |
|
233
Bumble
BMBL
$642M
| $7.06M | 0.01% |
360,894
| – | – |
|
234
Health Catalyst
HCAT
$239M
| $7.02M | 0.01% |
601,763
+2,851
| +0.5% | +$33.3K |
|
235
Relay Therapeutics
RLAY
$619M
| $6.85M | 0.01% |
415,663
+1,141
| +0.3% | +$18.8K |
|
236
Fortive
FTV
$16.2B
| $6.67M | 0.01% |
97,814
| – | – |
|
|
HUYA
237
Huya Inc
HUYA
$796M
| $6.37M | 0.01% |
1,765,711
| – | – |
|
238
Globus Medical
GMED
$8.27B
| $6.24M | 0.01% |
110,096
+48,109
| +78% | +$2.72M |
|
239
Compañía de Cervecerías Unidas
CCU
$2.29B
| $5.59M | 0.01% |
+357,900
| New | +$5.59M |
|
|
NBTX
240
Nanobiotix
NBTX
$429M
| $5.08M | ﹤0.01% |
1,400,000
| – | – |
|
241
Cardlytics
CDLX
$54.3M
| $4.84M | ﹤0.01% |
1,426,941
-9,279
| -0.6% | -$31.5K |
|
242
XP
XP
$9.56B
| $4.84M | ﹤0.01% |
407,875
| – | – |
|
|
TRHC
243
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $4.65M | ﹤0.01% |
831,278
-415
| -0% | -$2.32K |
|
244
LivePerson
LPSN
$90.1M
| $4.52M | ﹤0.01% |
1,025,591
-6,650
| -0.6% | -$29.3K |
|
|
SAGE
245
DELISTED
Sage Therapeutics
SAGE
| $3.99M | ﹤0.01% |
95,045
+160
| +0.2% | +$6.71K |
|
246
NextEra Energy, Inc.
NEE
$148B
| $3.97M | ﹤0.01% |
51,516
-43,610
| -46% | -$3.36M |
|
247
GitLab
GTLB
$7.93B
| $3.89M | ﹤0.01% |
113,404
+50,791
| +81% | +$1.74M |
|
|
NCNA
248
NuCana
NCNA
$6.09M
| $3.51M | ﹤0.01% |
3,659,030
| – | – |
|
|
CLLS
249
Cellectis
CLLS
$258M
| $3.16M | ﹤0.01% |
1,639,896
+1,040,000
| +173% | +$2.01M |
|
|
API
250
Agora
API
$313M
| $2.69M | ﹤0.01% |
744,300
| – | – |
|